CIBC Private Wealth Group’s BioMarin Pharmaceuticals BMRN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$17.7K Buy
322
+82
+34% +$4.51K ﹤0.01% 2061
2025
Q1
$13.4K Sell
240
-356
-60% -$19.9K ﹤0.01% 2142
2024
Q4
$40.8K Buy
596
+233
+64% +$15.9K ﹤0.01% 1755
2024
Q3
$25.5K Hold
363
﹤0.01% 2053
2024
Q2
$30K Sell
363
-185
-34% -$15.3K ﹤0.01% 1872
2024
Q1
$47.7K Buy
+548
New +$47.7K ﹤0.01% 1705
2023
Q1
Sell
-9,453
Closed -$549K 891
2022
Q4
$549K Sell
9,453
-47,709
-83% -$2.77M ﹤0.01% 600
2022
Q3
$4.85M Sell
57,162
-5,113
-8% -$433K 0.01% 373
2022
Q2
$5.16M Buy
62,275
+5
+0% +$414 0.01% 370
2022
Q1
$4.8M Hold
62,270
0.01% 403
2021
Q4
$5.5M Hold
62,270
0.01% 393
2021
Q3
$4.81M Hold
62,270
0.01% 397
2021
Q2
$5.2M Buy
62,270
+169
+0.3% +$14.1K 0.01% 394
2021
Q1
$4.69M Sell
62,101
-197
-0.3% -$14.9K 0.01% 403
2020
Q4
$5.46M Buy
62,298
+17,798
+40% +$1.56M 0.01% 377
2020
Q3
$3.39M Buy
+44,500
New +$3.39M 0.01% 399
2020
Q2
Sell
-28,460
Closed -$2.41M 620
2020
Q1
$2.41M Buy
28,460
+100
+0.4% +$8.45K 0.01% 383
2019
Q4
$2.4M Buy
28,360
+4,731
+20% +$400K 0.01% 445
2019
Q3
$1.59M Buy
23,629
+19
+0.1% +$1.28K 0.01% 492
2019
Q2
$2.02M Buy
23,610
+39
+0.2% +$3.34K 0.01% 468
2019
Q1
$2.09M Buy
23,571
+756
+3% +$67.2K 0.01% 456
2018
Q4
$1.94M Hold
22,815
0.01% 454
2018
Q3
$2.21M Buy
22,815
+5
+0% +$485 0.01% 480
2018
Q2
$2.15M Buy
22,810
+1,470
+7% +$138K 0.01% 477
2018
Q1
$1.73M Sell
21,340
-6,533
-23% -$530K 0.01% 528
2017
Q4
$2.49M Buy
27,873
+6,413
+30% +$572K 0.01% 462
2017
Q3
$2M Buy
+21,460
New +$2M 0.01% 493